Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery

Intensive Care Med. 2004 Mar;30(3):416-22. doi: 10.1007/s00134-003-2110-7. Epub 2004 Jan 8.

Abstract

Objective: Adequate restoration of intravascular volume remains an important maneuver in the management of the surgical patient. Influence of different volume replacement regimens on inflammation/endothelial activation in elderly surgical patients was assessed.

Design: Prospective, randomized study.

Setting: Surgical intensive care unit of a university-affiliated hospital.

Patients: Sixty-six patients >65 years undergoing major abdominal surgery.

Interventions: Ringer's lactate (RL; n=22), normal saline solution (NS; n=22) or a low-molecular HES (mean molecular weight 130 kD) with a low degree of substitution (0.4; HES 130/0.4; n=22) were administered after induction of anesthesia until the 1st postoperative day (POD) to keep central venous pressure between 8-12 mmHg.

Measurements and results: C-reactive protein, interleukins (IL-6, IL-8), adhesion molecules [endothelial leukocyte adhesion molecule-1 (ELAM-1) and intercellular adhesion molecule-1 (ICAM-1)] were measured prior to volume therapy at the end of surgery, 5 h after surgery and at the morning of the 1st POD. RL patients received 10,150+/-1,660 ml of RL, NS patients 10,220+/-1,770 ml of NS and the HES-treated group 2,850+/-300 ml of HES 130/0.4 and 2,810+/-350 ml of RL. Hemodynamics were similar in all groups. CRP, IL-6 and IL-8 plasma levels increased significantly higher in both crystalloid groups (IL-6 in the NS group: increase to 407+/-33 pg/ml; RL: increase to 377+/-35 pg/dl) than in the HES-130 treated group (IL-6: increase to 197+/-20 pg/dl). Plasma levels of ELAM-1 and ICAM remained almost unchanged in the HES 130-, but significantly increased in the RL- and NS-treated patients.

Conclusions: In elderly patients, markers of inflammation and endothelial injury and activation were significantly higher after crystalloid- than after HES 130/0.4-based volume replacement regimens.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Retracted Publication

MeSH terms

  • Abdomen / surgery*
  • Aged
  • Analysis of Variance
  • Cell Adhesion Molecules / blood
  • Crystalloid Solutions
  • Endothelium / metabolism
  • Endothelium / physiopathology*
  • Female
  • Fluid Therapy / methods*
  • Humans
  • Hydroxyethyl Starch Derivatives / therapeutic use*
  • Inflammation / metabolism
  • Inflammation / physiopathology*
  • Isotonic Solutions
  • Male
  • Perioperative Care / methods*
  • Plasma Substitutes / therapeutic use*
  • Prospective Studies
  • Statistics, Nonparametric

Substances

  • Cell Adhesion Molecules
  • Crystalloid Solutions
  • Hydroxyethyl Starch Derivatives
  • Isotonic Solutions
  • Plasma Substitutes